Clinical trial
The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy
NCT06318507 is registered in ClinicalTrials.gov with Pennington Biomedical Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy
- Lead sponsor
- Pennington Biomedical Research Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 11, 2024
- Completion date
- December 31, 2026
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.